Data search


search
Exact
Search

Results for MligTC455_33980

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_33980 84 1.76 Mlig455_059342, Mlig455_065591

Neo: -

Age: -

RXFP1

Mlig455_059342 {REF} {Length: 6748} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=112.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=81.9]; Leucine rich repeat [PF13855.8, score=60.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=35.5]; Lectin C-type domain [PF00059.23, score=31.8]; Leucine Rich Repeat [PF00560.35, score=19.5]} {Human: ENSG00000171509, RXFP1, relaxin family peptide receptor 1, [Score=194, Expect=7e-51]; ENSG00000133105, RXFP2, relaxin family peptide receptor 2, [Score=186, Expect=7e-48]} {Mouse: ENSMUSG00000053368, Rxfp2, relaxin/insulin-like family peptide receptor 2, [RH, Score=199, Expect=2e-52]} {Dmel: FBgn0039354, Lgr3, Leucine-rich repeat-containing G protein-coupled receptor 3, [Score=162, Expect=3e-40]} {Celegans: WBGene00020481, T13C2.6, [RH, Score=118, Expect=2e-26]} {Smed: dd_Smed_v6_17598_0_1, dd_Smed_v6_17598_0_1, [RH, Score=572, Expect=6e-177]} {RNA1509_31029} {RNA1310_10930} {RNA815_3776}

Mlig455_065591 {REF} {Length: 6849} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=109.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=101.1]; CUB domain [PF00431.22, score=64.8]; Leucine rich repeat [PF13855.8, score=60.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=34.2]; Lectin C-type domain [PF00059.23, score=31.3]; Leucine Rich Repeat [PF00560.35, score=19.5]} {Human: ENSG00000171509, RXFP1, relaxin family peptide receptor 1, [RH, Score=208, Expect=4e-55]; ENSG00000133105, RXFP2, relaxin family peptide receptor 2, [RH, Score=199, Expect=5e-52]} {Mouse: ENSMUSG00000053368, Rxfp2, relaxin/insulin-like family peptide receptor 2, [RH, Score=209, Expect=8e-56]} {Dmel: FBgn0039354, Lgr3, Leucine-rich repeat-containing G protein-coupled receptor 3, [RH, Score=177, Expect=6e-45]} {Celegans: WBGene00020481, T13C2.6, [RH, Score=117, Expect=6e-26]} {Smed: dd_Smed_v6_17598_0_1, dd_Smed_v6_17598_0_1, [RH, Score=579, Expect=3e-175]} {RNA1509_31029} {RNA1310_10930, RNA1509_31029} {RNA1509_31029, RNA815_3776}

Cumulative graph for MligTC455_33980

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -2.019 2.003 1.00000 1.00000
RegionR2 -1.202 2.003 1.00000 1.00000
RegionR3 3.329 2.003 0.00501 0.09513
RegionR4 0.935 2.003 0.32106 0.63786
RegionR5 1.413 2.003 0.16746 0.43406
RegionR6 0.019 2.003 0.58096 1.00000
RegionR7 -1.397 2.003 1.00000 1.00000
RegionR8 -1.077 2.003 1.00000 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 0.112 2.003 0.99998 1.00000
RegenerationR2 4.826 2.003 0.00054 0.03187
RegenerationR3 2.023 2.003 0.07435 0.45536
RegenerationR4 2.548 2.003 0.07750 0.44246
RegenerationR5 1.429 2.003 0.19525 0.62678
RegenerationR6 2.107 2.003 0.15732 0.48509
RegenerationBL -1.358 2.003 1.00000 1.00000
RegenerationTP 3.675 2.003 0.17146 0.60402


Genes with expression patterns similar to MligTC455_33980

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_33980 84 1.76 Mlig455_059342, Mlig455_065591

Neo: -

Age: -

RXFP1 5 1.000 1.000 - 1.000 1.000 1.000

Mlig455_059342 {REF} {Length: 6748} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=112.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=81.9]; Leucine rich repeat [PF13855.8, score=60.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=35.5]; Lectin C-type domain [PF00059.23, score=31.8]; Leucine Rich Repeat [PF00560.35, score=19.5]} {Human: ENSG00000171509, RXFP1, relaxin family peptide receptor 1, [Score=194, Expect=7e-51]; ENSG00000133105, RXFP2, relaxin family peptide receptor 2, [Score=186, Expect=7e-48]} {Mouse: ENSMUSG00000053368, Rxfp2, relaxin/insulin-like family peptide receptor 2, [RH, Score=199, Expect=2e-52]} {Dmel: FBgn0039354, Lgr3, Leucine-rich repeat-containing G protein-coupled receptor 3, [Score=162, Expect=3e-40]} {Celegans: WBGene00020481, T13C2.6, [RH, Score=118, Expect=2e-26]} {Smed: dd_Smed_v6_17598_0_1, dd_Smed_v6_17598_0_1, [RH, Score=572, Expect=6e-177]} {RNA1509_31029} {RNA1310_10930} {RNA815_3776}

Mlig455_065591 {REF} {Length: 6849} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=109.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=101.1]; CUB domain [PF00431.22, score=64.8]; Leucine rich repeat [PF13855.8, score=60.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=34.2]; Lectin C-type domain [PF00059.23, score=31.3]; Leucine Rich Repeat [PF00560.35, score=19.5]} {Human: ENSG00000171509, RXFP1, relaxin family peptide receptor 1, [RH, Score=208, Expect=4e-55]; ENSG00000133105, RXFP2, relaxin family peptide receptor 2, [RH, Score=199, Expect=5e-52]} {Mouse: ENSMUSG00000053368, Rxfp2, relaxin/insulin-like family peptide receptor 2, [RH, Score=209, Expect=8e-56]} {Dmel: FBgn0039354, Lgr3, Leucine-rich repeat-containing G protein-coupled receptor 3, [RH, Score=177, Expect=6e-45]} {Celegans: WBGene00020481, T13C2.6, [RH, Score=117, Expect=6e-26]} {Smed: dd_Smed_v6_17598_0_1, dd_Smed_v6_17598_0_1, [RH, Score=579, Expect=3e-175]} {RNA1509_31029} {RNA1310_10930, RNA1509_31029} {RNA1509_31029, RNA815_3776}
2. MligTC455_28572 795 16.56 Mlig455_003711, Mlig455_003877

Neo: -

Age: logFC(26M/2M)=0.820

Region-enriched R3: 3.765/0.00000

3.21 - 0.710 - 0.969 0.745 0.786

Mlig455_003711 {REF} {Length: 988} {RNA1509_11217} {RNA1310_24401} {RNA815_10016}

Mlig455_003877 {REF} {Length: 2523} {RNA1509_11217} {RNA1310_24401} {RNA815_10016}
3. MligTC455_20084 569 11.85 Mlig455_034786

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.575

Region-enriched R3: 2.972/0.00007
Region-enriched R4: 2.323/0.01179

DNASE1L2 2.467 - 0.727 - 0.957 - 0.783 Mlig455_034786 {REF} {Length: 1822} {Pfam: Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=38.1]} {Human: ENSG00000167968, DNASE1L2, deoxyribonuclease 1 like 2, [RH, Score=185, Expect=8e-55]; ENSG00000163687, DNASE1L3, deoxyribonuclease 1 like 3, [RH, Score=185, Expect=2e-54]; ENSG00000213918, DNASE1, deoxyribonuclease 1, [RH, Score=181, Expect=2e-53]} {Mouse: ENSMUSG00000025279, Dnase1l3, deoxyribonuclease 1-like 3, [RH, Score=184, Expect=3e-54]; ENSMUSG00000024136, Dnase1l2, deoxyribonuclease 1-like 2, [RH, Score=180, Expect=4e-53]; ENSMUSG00000005980, Dnase1, deoxyribonuclease I, [RH, Score=178, Expect=3e-52]} {RNA1509_8194} {RNA1310_18116, RNA1509_8194} {RNA1509_8194, RNA815_13867}
4. MligTC455_36084 2401 50.02 Mlig455_050285

Neo: -

Age: Down-Down-Up, logFC(26M/2M)=-0.672

Region-enriched R4: 2.667/0.00000
Region-enriched R3: 2.443/0.00000
Region-enriched R5: 1.563/0.00122

2.395 - 0.726 - 0.961 - 0.708 Mlig455_050285 {REF} {Length: 2917} {Pfam: Transforming growth factor beta like domain [PF00019.22, score=44.8]} {RNA1509_5434} {RNA1310_5336} {RNA815_1739.1}
5. MligTC455_36083 1788 37.26 Mlig455_050276

Neo: -

Age: Down-Down-Up

Region-enriched R3: 2.753/0.00000
Region-enriched R4: 2.492/0.00000
Region-enriched R5: 1.839/0.00004

2.365 - 0.707 - 0.957 - 0.701 Mlig455_050276 {REF} {Length: 2874} {Pfam: Transforming growth factor beta like domain [PF00019.22, score=19.6]} {RNA1509_5434} {RNA1310_5336} {RNA815_1739.1}
6. MligTC455_06252 20 0.42 Mlig455_050158

Neo: -

Age: -

1.83 - - - - 0.958 0.872 Mlig455_050158 {REF} {Length: 761} {NoTransDecoderORF} {RNA1310_135845}
7. MligTC455_23093 345 7.19 Mlig455_021893

Neo: -

Age: Down-Up-Up

Region-enriched R3: 3.624/0.00000

1.777 - 0.825 - 0.952 - - Mlig455_021893 {REF} {Length: 1735} {RNA1509_30322, RNA1509_50391} {RNA1310_32503, RNA1509_50391} {RNA1509_50391, RNA815_39630}
8. MligTC455_03672 27 0.57 Mlig455_067166

Neo: -

Age: Up-Down-Up

TRPM2 1.774 - - - - 0.952 0.822 Mlig455_067166 {REF} {Length: 3486} {Pfam: SLOG in TRPM [PF18139.3, score=155.6]; SLOG in TRPM, prokaryote [PF18171.3, score=60.9]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=231, Expect=2e-62]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=215, Expect=2e-57]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=175, Expect=1e-44]} {Celegans: WBGene00001795, gtl-1, GTL-1; Gon-Two Like (TRP subfamily), [Score=194, Expect=1e-50]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [RH, Score=559, Expect=0.0]} {RNA1509_51848} {RNA1310_644} {RNA815_9231}
9. MligTC455_33610 363 7.57 Mlig455_017447

Neo: Germline

Age: Up-Down-Up, logFC(26M/2M)=2.665

Region-enriched R4: 3.381/0.00901

ASAH2 0.966 - - - 0.966 - - Mlig455_017447 {REF} {Length: 2857} {Pfam: Neutral/alkaline non-lysosomal ceramidase, N-terminal [PF04734.15, score=705.2]; Neutral/alkaline non-lysosomal ceramidase, C-terminal [PF17048.7, score=155.5]} {Human: ENSG00000188611, ASAH2, N-acylsphingosine amidohydrolase 2, [RH, Score=628, Expect=0.0]} {Mouse: ENSMUSG00000024887, Asah2, N-acylsphingosine amidohydrolase 2, [RH, Score=613, Expect=0.0]} {Dmel: FBgn0039774, CDase, Ceramidase, [RH, Score=594, Expect=0.0]} {Smed: dd_Smed_v6_1726_0_1, dd_Smed_v6_1726_0_1, [RH, Score=664, Expect=0.0]} {RNA1509_17200} {RNA1310_8395.1} {RNA815_2759}
10. MligTC455_11282 124 2.58 Mlig455_017457, Mlig455_030936

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.648

FDXACB1 0.965 - - - - 0.965 -

Mlig455_017457 {REF} {Length: 3560} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=28.8]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=1e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=4e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1509_12220} {RNA1310_10541} {RNA815_15665}

Mlig455_030936 {REF} {Length: 2975} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=29.2]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=2e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=6e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1310_10541} {RNA815_15665}
11. MligTC455_33611 478 9.95 Mlig455_034367

Neo: -

Age: Up-Up-Up, logFC(26M/2M)=1.080

Region-enriched R4: 2.761/0.00774
Region-enriched R3: 2.079/0.04141

ASAH2 0.963 - - - 0.963 - - Mlig455_034367 {REF} {Length: 2561} {Pfam: Neutral/alkaline non-lysosomal ceramidase, N-terminal [PF04734.15, score=706.1]; Neutral/alkaline non-lysosomal ceramidase, C-terminal [PF17048.7, score=154.5]} {Human: ENSG00000188611, ASAH2, N-acylsphingosine amidohydrolase 2, [RH, Score=627, Expect=0.0]} {Mouse: ENSMUSG00000024887, Asah2, N-acylsphingosine amidohydrolase 2, [RH, Score=614, Expect=0.0]} {Dmel: FBgn0039774, CDase, Ceramidase, [RH, Score=597, Expect=0.0]} {Smed: dd_Smed_v6_1726_0_1, dd_Smed_v6_1726_0_1, [RH, Score=662, Expect=0.0]} {RNA1509_4146} {RNA1310_8395.1} {RNA815_2759}
12. MligTC455_31813 5 0.11 Mlig455_006758, Mlig455_019241

Neo: -

Age: -

0.955 - - - - 0.955 -

Mlig455_006758 {REF} {Length: 3990} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=122.8]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=68.2, Expect=2e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1}

Mlig455_019241 {REF} {Length: 2474} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=112.3]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=62.8, Expect=1e-11]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609}
13. MligTC455_08383 49 1.01 Mlig455_001288

Neo: -

Age: -

ZMYND15 0.953 - - - - - 0.953 Mlig455_001288 {REF} {Length: 1845} {Human: ENSG00000141497, ZMYND15, zinc finger MYND-type containing 15, [Score=99.8, Expect=7e-22]} {Mouse: ENSMUSG00000040829, Zmynd15, zinc finger, MYND-type containing 15, [Score=102, Expect=3e-23]} {Smed: dd_Smed_v6_8776_0_2, dd_Smed_v6_8776_0_2, [Score=132, Expect=5e-35]} {RNA1509_45183} {RNA1310_24792} {RNA815_22964}
14. MligTC455_21680 724 15.08 Mlig455_000605, Mlig455_034134

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.732

Region-enriched R3: 2.466/0.00387
Region-enriched R4: 2.148/0.02841
Region-enriched R5: 1.792/0.02276

ENDOU 0.953 - - - 0.953 - -

Mlig455_000605 {REF} {Length: 1158} {Pfam: Endoribonuclease XendoU [PF09412.12, score=131.5]} {Human: ENSG00000111405, ENDOU, endonuclease, poly(U) specific, [Score=104, Expect=1e-25]} {Mouse: ENSMUSG00000022468, Endou, endonuclease, polyU-specific, [Score=112, Expect=2e-28]} {Dmel: FBgn0030251, CG2145, [Score=91.7, Expect=1e-20]} {Celegans: WBGene00010488, endu-1, Poly(U)-specific endoribonuclease homolog, [Score=95.5, Expect=5e-23]} {Smed: dd_Smed_v6_9109_0_1, dd_Smed_v6_9109_0_1, [Score=88.6, Expect=9e-21]} {RNA1509_53582} {RNA1310_25491.1} {RNA815_11062.1}

Mlig455_034134 {REF} {Length: 1307} {Pfam: Endoribonuclease XendoU [PF09412.12, score=171.0]} {Human: ENSG00000111405, ENDOU, endonuclease, poly(U) specific, [Score=124, Expect=3e-32]} {Mouse: ENSMUSG00000022468, Endou, endonuclease, polyU-specific, [Score=125, Expect=2e-32]} {Dmel: FBgn0030251, CG2145, [Score=102, Expect=6e-24]} {Celegans: WBGene00010488, endu-1, Poly(U)-specific endoribonuclease homolog, [Score=104, Expect=1e-25]} {Smed: dd_Smed_v6_9109_0_1, dd_Smed_v6_9109_0_1, [Score=99.0, Expect=5e-24]} {RNA1509_35253, RNA1509_53582} {RNA1310_25491.1, RNA1509_35253} {RNA1509_35253, RNA815_11062.1}
15. MligTC455_00438 6 0.13 Mlig455_015467

Neo: -

Age: -

0.95 - - - - 0.950 - Mlig455_015467 {REF} {Length: 251} {NoTransDecoderORF}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA